FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Info Collection Extension for Animal Drug Reporting

Federal Register notice: FDA submits to OMB an information collection extension for Animal Drug Adverse Event Reporting.

Human Drugs

Group Seeks Removal of Conflicted Panel Member

Consumer-health advocacy group Citizens for Health urges FDA commissioner Scott Gottlieb to remove a Pew Charitable Trusts representative from the age...

Medical Devices

Safety Alert on Therakos Cellex Photopheresis System

FDA issues a safety alert warning healthcare providers of venous thromboembolism, including pulmonary embolism, in patients who received autologous im...

Human Drugs

FDA Reminds Drug Makers About Status Report Due 2/14

FDA reminds all ANDA and NDA holders about a one-time report that is due 2/14 on the market status for all approved drug products.

Medical Devices

United Health Products PMA Filed for HemoStyp

United Health Products files a PMA for HemoStyp for use in internal procedures.

Human Drugs

CDER/CBER Plan on Data Standards

CDER and CBER release their Data Standards Strategy FY2018-FY2022 that commits the centers to continue the development, implementation, and maintenanc...

Human Drugs

FDA Approves Amag Pharma Expanded Label for Feraheme

FDA approves an Amag Pharmaceuticals supplemental NDA to broaden the existing label for Feraheme (ferumoxytol injection) beyond the current chronic ki...

FDA General

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 2/2/2018.

FDA General

Since Our Last Issue ...

Industry news you may have missed since our last issue.

Human Drugs

Regulatory Review Period Determined for Duavee

Federal Register notice: FDA determines for patent extension purposes that the regulatory review period for Duavee (conjugated estrogens/bazedoxifene ...